Catheter ablation of atrial fibrillation: A treatment frontier

Journal of Interventional Cardiac Electrophysiology

Volumn 15, Issue 3, 2006, Pages 141-143

  Domanski, Michael ^a   Waldo, Albert L ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CATHETER ABLATION; COMORBIDITY; EDITORIAL; ESOPHAGUS FISTULA; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART TAMPONADE; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VEIN OBSTRUCTION; RISK ASSESSMENT; STROKE; TACHYCARDIA;

ATRIAL FIBRILLATION; CATHETER ABLATION; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 33749441618     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-9024-6     Document Type: Editorial

References (22)

1. Benjamin, E., Wolf, P., D'Agnostino, R., Silbershatz, H., Kannel, W., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946-952.
2. Lloyd-Jones, D., Wang, T., Leip, E., Larson, M., Levy, D., Vasan, R., et al. (2004). Lifetime risk for development of atrial fibrillation. The Framingham Heart Study. Circulation, 110, 1042-1046.
3. Go, A., Hylek, E., Phillips, K., Chang, Y., Henault, L., Selby, J., et al. (2001). Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Trial. JAMA, 285, 2370-2375.
4. The AFFIRM Investigators (2002). A comparison of rate control and rhythm control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine, 347, 1825-1833.
5. The AFFIRM Investigators (2004). Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation, 109, 1509-1513.
6. Cappato, R., Calkins, H., Chen, S., Davies, W., Lesaka, Y., Kalman, J., et al. (2005). Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation, 111, 1100-1105.
7. Cheema, A., Vasamreddy, C. R., Dalal, D., Marine, J. E., Dong, J., Henrikson, C. A., et al. (2006). Long-term single procedure efficacy of catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. DOI: 10.1007/s10840-006-9005-9.
8. Haissaguerre, M., Jais, P., Shah, D., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine, 339, 659-666.
9. Hsu, L., Jais, P., Sanders, P., et al. (2004). Catheter ablation for atrial fibrillation in congestive heart failure. New England Journal of Medicine, 351, 2373-2383.
10. Israel, C., Gronefield, G., Ehrlich, J., Li, Y., & Hohnloser, S. (2004). Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. Journal of the American College of Cardiology, 43, 47-52.
11. Nadamanee, K., McKenzie, J., Kosar, E., et al. (2004). A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. Journal of the American College of Cardiology, 43, 2044-2053.
12. Oral, H., Papone, C., Chugh, A., et al. (2006). Circumferential pulmonary-vein ablation for chronic atrial fibrillation. New England Journal of Medicine, 354, 967-969.
13. Page, R., Wilkinson, W., Clair, W., McCarthy, E., & Pritchett, E. (1994). Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation, 89, 224-227.
14. Journal of the American College of Cardiology, 2004; 43, 47-52.
15. Pappone, C., Oral, H., Santinelli, V., Vicedomini, G., Lang, C., Manguso, F., et al. (2005). Atrio-esophageal fistula as a complication of transcatheter ablation of atrial fibrillation. Treatment of symptomatic atrial fibrillation. JAMA, 293, 2634-2640.
16. Pappone, C., Rosanio, S., Augello, G., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes for from a controlled non-randomized long-term study. Journal of the American College of Cardiology, 42, 185-197.
17. Saksena, S., Skadsberg, N., Rao, H., Filipecki, A. (2005). Biatrial and 3-dimensional mapping of spontaneous atrial arrhythmias in patients with refractory atrial fibrillation. Journal of Cardiovascular Electrophysiology, 16(5), 494-504, May.
18. Sanders, P., Berenfeld, O., Hocini, M., Jais, P., Vaidyanathan, R., Hsu, L. F., et al. (2005). Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation, 112(6), 789-797, Aug 9.
19. Waldo, A. (2005). The interrelationship between atrial fibrillation and atrial flutter. Progress in Cardiovascular Disease, 48, 41-56.
20. Waldo, A. (2006). A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: There remains an unmet need. American Heart Journal, 151, 771-779.
21. Wanzi, O., Marrouche, N., Martin, D., et al. (2004). Radiofrequency ablation versus antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. Circulation, 109, 2724-2726.
22. Wolf, P. A., et al. (1987). Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham Study. Archives of Internal Medicine, 147, 1561-1564.